📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-16-0881

PubMed Identifier: 28637716

Publication URI: http://europepmc.org/abstract/MED/28637716

Type: Journal Article/Review

Volume: 16

Parent Publication: Molecular cancer therapeutics

Issue: 10

ISSN: 1535-7163